Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emina Omerovic

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cardiovascular Diabetology|June 24, 2011
YKL-40 levels are independently associated with albuminuria in type 2 diabetesAnne K Røndbjerg, Emina Omerovic, Henrik Vestergaard
The Journal of Pediatrics|February 7, 2021
Infant Regulation: Associations with Child Language Development in a Longitudinal CohortFallon Cook, Laura Conway, Emina Omerovic, et al.
Arthritis|March 12, 2015
Antibodies to infliximab and adalimumab in patients with rheumatoid arthritis in clinical remission: a cross-sectional studyGrith P Eng, Klaus Bendtzen, Henning Bliddal, et al.
Rheumatology (Oxford, England)|June 19, 2014
Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIOBente Glintborg, Bjorn Gudbjornsson, Niels Steen Krogh, et al.
Annals of the Rheumatic Diseases|September 5, 2012
Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO RegistryLene Dreyer, Lene Mellemkjær, Anne Rødgaard Andersen, et al.
Annals of the Rheumatic Diseases|July 27, 2014
Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis: results from the DANBIO registryPil Højgaard, Bente Glintborg, Merete Lund Hetland, et al.
Annals of the Rheumatic Diseases|November 7, 2018
To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registryBente Glintborg, Anne Gitte Loft, Emina Omerovic, et al.
Annals of the Rheumatic Diseases|January 25, 2019
Response to ''To switch or not to switch': the missing piece in the puzzle of biosimilar literature?' by Scherlinger <i>et al</i>Bente Glintborg, Anne Gitte Loft, Emina Omerovic, et al.
Annals of the Rheumatic Diseases|December 22, 2018
Response to: 'Mandatory, cost-driven switching from originator etanercept to its biosimilar SB<sub>4</sub>: possible fallout on non-medical switching' by Cantini and BenucciBente Glintborg, Anne Gitte Loft, Emina Omerovic, et al.
Biological Psychiatry|December 9, 2023
Genome-Wide Analyses of Vocabulary Size in Infancy and Toddlerhood: Associations With Attention-Deficit/Hyperactivity Disorder, Literacy, and Cognition-Related TraitsEllen Verhoef, Andrea G Allegrini, Philip R Jansen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cardiovascular Diabetology|June 24, 2011
YKL-40 levels are independently associated with albuminuria in type 2 diabetesAnne K Røndbjerg, Emina Omerovic, Henrik Vestergaard
The Journal of Pediatrics|February 7, 2021
Infant Regulation: Associations with Child Language Development in a Longitudinal CohortFallon Cook, Laura Conway, Emina Omerovic, et al.
Arthritis|March 12, 2015
Antibodies to infliximab and adalimumab in patients with rheumatoid arthritis in clinical remission: a cross-sectional studyGrith P Eng, Klaus Bendtzen, Henning Bliddal, et al.
Rheumatology (Oxford, England)|June 19, 2014
Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIOBente Glintborg, Bjorn Gudbjornsson, Niels Steen Krogh, et al.
Annals of the Rheumatic Diseases|September 5, 2012
Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO RegistryLene Dreyer, Lene Mellemkjær, Anne Rødgaard Andersen, et al.
Annals of the Rheumatic Diseases|July 27, 2014
Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis: results from the DANBIO registryPil Højgaard, Bente Glintborg, Merete Lund Hetland, et al.
Annals of the Rheumatic Diseases|November 7, 2018
To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registryBente Glintborg, Anne Gitte Loft, Emina Omerovic, et al.
Annals of the Rheumatic Diseases|January 25, 2019
Response to ''To switch or not to switch': the missing piece in the puzzle of biosimilar literature?' by Scherlinger <i>et al</i>Bente Glintborg, Anne Gitte Loft, Emina Omerovic, et al.
Annals of the Rheumatic Diseases|December 22, 2018
Response to: 'Mandatory, cost-driven switching from originator etanercept to its biosimilar SB<sub>4</sub>: possible fallout on non-medical switching' by Cantini and BenucciBente Glintborg, Anne Gitte Loft, Emina Omerovic, et al.
Biological Psychiatry|December 9, 2023
Genome-Wide Analyses of Vocabulary Size in Infancy and Toddlerhood: Associations With Attention-Deficit/Hyperactivity Disorder, Literacy, and Cognition-Related TraitsEllen Verhoef, Andrea G Allegrini, Philip R Jansen, et al.
Pageof 1